Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life

[1]  R. Audisio,et al.  Age specific recruitment and retention to a large multicentre observational breast cancer trial in older women: The Age Gap Trial , 2020, Journal of geriatric oncology.

[2]  R. Audisio,et al.  Breast cancer surgery in older women: outcomes of the Bridging Age Gap in Breast Cancer study , 2020, The British journal of surgery.

[3]  S. Walters,et al.  Quality of life versus length of life considerations in cancer patients: A systematic literature review , 2019, Psycho-oncology.

[4]  M. Reed,et al.  Efficient development and usability testing of decision support interventions for older women with breast cancer , 2019, Patient preference and adherence.

[5]  L. Esserman,et al.  Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents , 2018, JAMA surgery.

[6]  M. Reed,et al.  Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer‐specific survival , 2018, The British journal of surgery.

[7]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[8]  Amy P Abernethy,et al.  Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). , 2015, JAMA oncology.

[9]  M. Reed,et al.  Case‐mix analysis and variation in rates of non‐surgical treatment of older women with operable breast cancer , 2015, The British journal of surgery.

[10]  K. Brain,et al.  The information and decision support needs of older women (>75 yrs) facing treatment choices for breast cancer: a qualitative study , 2014, Psycho-oncology.

[11]  I. Ellis,et al.  A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  J. Gazet,et al.  A randomised trial comparing tamoxifen vs. surgery in patients over the age of 70 with operable breast cancer--final results after 28 years of follow-up. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[14]  I. Ellis,et al.  Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre , 2011, British Journal of Cancer.

[15]  P. Ellis,et al.  Breast cancer in older women: trials and tribulations. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[16]  L. Husain,et al.  Choices in cancer treatment: a qualitative study of the older women's (>70 years) perspective , 2008, Psycho-oncology.

[17]  Douglas G Altman,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. , 2014, International journal of surgery.

[18]  Stephen J. Clarke,et al.  Nutritional Assessment in Cancer: Comparing the Mini-Nutritional Assessment (MNA) With the Scored Patient-Generated Subjective Global Assessment (PGSGA) , 2005, Nutrition and cancer.

[19]  M. Reed,et al.  Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). , 2014, The Cochrane database of systematic reviews.

[20]  P. Therasse,et al.  Evaluation of response: new and standard criteria. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  D B Evans,et al.  Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Elledge,et al.  Tumor characteristics and clinical outcome of elderly women with breast cancer. , 2000, Journal of the National Cancer Institute.

[23]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[24]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[25]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[26]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[27]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[28]  I. Ellis,et al.  The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.

[29]  Ross Camidge,et al.  The European Organisation for Research and Treatment of Cancer , 2002 .

[30]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[31]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.